Innovation in pharmaceutical research and development (R&D) hinges on access to high-quality, reliable chemical intermediates. 2-(2-Bromoethyl)-1,3-dioxolane, cataloged under CAS 18742-02-4, is one such compound that plays a significant role in the synthesis of active pharmaceutical ingredients (APIs) and other critical drug precursors. Its unique chemical structure makes it a valuable tool for medicinal chemists.

Professionals in the pharmaceutical sector often use specific search terms like 'buy 2-(2-bromoethyl)-1,3-dioxolane' when they need this intermediate for their projects. The compound’s typical appearance as a colorless liquid and its established purity of 96% are crucial for ensuring the reproducibility and success of complex synthetic routes in drug discovery. This intermediate, with its C5H9BrO2 molecular formula, allows for the controlled introduction of specific functional groups necessary for building the scaffolds of new therapeutic agents.

When sourcing for pharmaceutical R&D, particularly from international markets, identifying a trusted 'chemical intermediate supplier in China' is a common strategy to manage costs and supply chain efficiency. Buyers frequently inquire about 'CAS 18742-02-4 price' to compare offerings from different manufacturers. It is essential for R&D managers to partner with suppliers who can consistently deliver material that meets pharmaceutical-grade specifications and provide comprehensive documentation.

The versatility of 2-(2-Bromoethyl)-1,3-dioxolane allows it to be used in various reactions, including alkylations and cyclizations, which are fundamental to creating diverse molecular structures. For companies involved in early-stage drug discovery or process optimization, having a dependable source to purchase this chemical is critical. This often involves reaching out to manufacturers for quotes and samples to validate quality before committing to larger orders.

In conclusion, 2-(2-Bromoethyl)-1,3-dioxolane is a vital intermediate for pharmaceutical R&D. By prioritizing purity, understanding its synthetic applications, and diligently selecting a reliable manufacturer or supplier, research teams can ensure they have the essential building blocks to drive innovation and accelerate the development of life-saving medicines.